The telomerase enzyme TERT may offer cardiovascular protection through mechanisms completely separate from its famous role in chromosome maintenance, potentially reshaping how we approach heart disease prevention in aging adults. This finding challenges the conventional view that TERT's health benefits stem solely from preserving telomeres.
Mouse studies revealed that TERT deficiency accelerates pathological heart remodeling under pressure stress by activating a specific molecular cascade involving CNBP protein and the THBS3/ITGB1 signaling pathway. When TERT levels were insufficient, hearts showed more severe structural changes and dysfunction when subjected to pressure overload conditions that mimic hypertension or valve disease. The research identified CNBP as a key mediator that becomes hyperactive in TERT-deficient conditions, subsequently triggering thrombospondin-3 and integrin beta-1 signaling that promotes harmful cardiac tissue changes.
This discovery adds crucial nuance to our understanding of telomerase biology beyond simple cellular aging. While TERT supplementation strategies have primarily focused on telomere lengthening for longevity benefits, these non-telomeric protective functions suggest broader therapeutic potential for cardiovascular health. The CNBP-THBS3/ITGB1 pathway represents a novel target for heart failure prevention, particularly relevant as cardiovascular disease remains the leading cause of death in aging populations. However, these findings require validation in human studies before clinical applications emerge. The research also raises questions about whether current approaches to measuring 'biological age' through telomere length adequately capture TERT's full spectrum of health-protective activities throughout the body.
